🔎 Trials Near Me

Почетна › Рак јетре (хепатоцелуларни карцином) › Kalifornija

Kliničke studije za Рак јетре (хепатоцелуларни карцином) u državi Kalifornija

55 studija za Рак јетре (хепатоцелуларни карцином) traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • The City of Hope National Medical Center, Duarte
  • Hoag Memorial Hospital, Newport Beach
Тражи се учесникФаза 1
Узраст 16 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07197554

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
  • и још 1
Тражи се учесникФаза 2
Узраст од 18 до 100 · Оба пола · Ажурирано 10. 11. 2026. · NCT07219459

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
  • Naval Medical Center -San Diego, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  • Providence St. Jude, Fullerton
  • Cedars-Sinai Medical Center, Los Angeles
  • Mission Hospital, Mission Viejo
  • и још 3
Тражи се учесникОпсервациона студија
Узраст 22 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT06486454

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

  • The Angeles Clinic and Research Institute (#601), Los Angeles
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07636785

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA06-0, Los Angeles
  • USA16-0, Los Angeles
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06953089

A Study of MGC026 in Participants With Advanced Solid Tumors

  • The Angeles Clinic and Research Institute, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT06242470

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

  • Clinical Trial Site, La Jolla
  • Clinical Trial Site, Los Angeles
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06600321

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Los Angeles Cancer Network, Los Angeles
  • Pih Health Hematology Medical Oncology, Whittier
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06330064

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT04472767

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06811116

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

  • City Of Hope, Duarte
  • Local Institution - 0070, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07291076

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

  • Norris Comprehensive Cancer Center, Los Angeles
  • University of California Irvine Medical Center, Orange
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT05440708

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

  • Duarte, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06764316

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 125, Los Angeles
  • Research Site 133, Los Angeles
  • Research Site 103, Los Angeles
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT05914116

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
  • и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06582017

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCSF Medical Center at Mount Zion, San Francisco
  • Stanford Cancer Institute, Stanford
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06915753

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

  • Research Site, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06795022

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

  • City of Hope National Medical Center /ID# 258645, Duarte
  • UCSF Medical Center - Mount Zion /ID# 257705, San Francisco
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06084481

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

  • Research Site, Los Angeles
  • Research Site, Palo Alto
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT06921785

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UCI Health - Irvine Infusion Pharmacy ACC, Irvine
  • UCI Health - Irvine, Irvine
  • и још 8
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227012

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of California, Los Angeles (UCLA), Los Angeles
  • Stanford Cancer Institute, Stanford University, Palo Alto
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05919264

A Study of ZW251 in Participants With Advanced Solid Tumors

  • UCSF Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT07164313

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #59, Santa Barbara
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT05176483

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

  • Research Facility, Orange
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06726161

National Liver Cancer Screening Trial

  • University of Southern California, Los Angeles
  • Stanford University, Redwood City
  • Kaiser Permanente, Roseville
  • и још 1
Тражи се учесникФаза 4
Узраст од 18 до 85 · Оба пола · Ажурирано 25. 9. 2026. · NCT06084234

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

  • City of Hope National Medical Center, Duarte
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06427941

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

  • City of Hope, Duarte
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT04864054

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT05497531

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital of Orange County, Orange
  • UCSF Medical Center-Mission Bay, San Francisco
Тражи се учесникФаза 1/2
12 Months – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT04851119

Patient-Derived Xenografts to Reduce Cancer Health Disparities

  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • University of California Davis Comprehensive Cancer Center, Sacramento
Тражи се учесникОпсервациона студија
Узраст од 21 до 100 · Оба пола · Ажурирано 20. 8. 2026. · NCT04410302

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park
  • Palo Alto Medical Foundation-Fremont, Fremont
  • и још 11
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07166406

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

  • University of California, San Francisco, San Francisco
  • John Muir Medical Center-Walnut Creek, Walnut Creek
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 14. 8. 2026. · NCT04221893

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
  • University of California Los Angeles Rheumatology, Westwood, Los Angeles
Тражи се учесникФаза 2
Узраст 8 и старији · Оба пола · Ажурирано 27. 7. 2026. · NCT05503797

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05208762

Multi-analyte Blood Test Clinical Trial

  • Gastroenterology and Liver Institute, Escondido
  • Providence Facey Medical Foundation, Mission Hills
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT05199259

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

  • City of Hope Medical Center, Duarte
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT06342414

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

  • City of Hope Nat Medical Ctr, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07224750

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF Benioff Children's Hospitals, San Francisco
Тражи се учесникФаза 1/2
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 7. 2026. · NCT04634357

Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)

  • City of Hope Medical Center, Duarte
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT07265271

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.